or Try an Advanced Search...

    Growth Hormone Deficiency Stocks List

    Symbol Grade Name % Change
    LLY A Eli Lilly and Company 1.83
    ASND B Ascendis Pharma A/S 1.21
    RANI D Rani Therapeutics Holdings, Inc. -0.53
    LUMO F Lumos Pharma, Inc. 0.45
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Growth Hormone Diabetes Biopharmaceutical Biotechnology Growth Hormone Therapy Hypertension Life Sciences Osteoporosis Peptide Hormones Pulmonary Arterial Hypertension Acromegaly Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression

    Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Deficiency stocks.

    Symbol Grade Name Weight
    IHE B iShares U.S. Pharmaceutical ETF 23.55
    OZEM B Roundhill GLP-1 & Weight Loss ETF 21.39
    MEDI C Harbor Health Care ETF 21.21
    MEDX B Horizon Kinetics Medical ETF 16.22
    THNR B Amplify Weight Loss Drug & Treatment ETF 15.58
    View all Growth Hormone Deficiency ETFs...
    Compare ETFs
    Compare IHE to MEDI Compare IHE to THNR Compare OZEM to THNR

        Growth Hormone Deficiency Stocks Recent News

        Date Stock Title
        Jul 5 LLY Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
        Jul 5 LLY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 LLY Eli Lilly Remains an Equities Outlier
        Jul 5 ASND Pendopharm and Ascendis to distribute hypoparathyroidism treatment
        Jul 5 LLY Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
        Jul 5 ASND Macy's, Ascendis Pharma And 3 Stocks To Watch Heading Into Friday
        Jul 4 LLY Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
        Jul 4 ASND Pendopharm signs distribution agreement with Ascendis Pharma for TransCon PTH in Canada
        Jul 4 ASND Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada
        Jul 4 LLY NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
        Jul 4 LLY Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
        Jul 4 LLY FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
        Jul 4 LLY Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
        Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
        Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
        Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
        Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
        Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
        Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
        Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Growth Hormone Diabetes Biopharmaceutical Biotechnology Growth Hormone Therapy Hypertension Life Sciences Osteoporosis Peptide Hormones Pulmonary Arterial Hypertension Acromegaly Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression
        Growth Hormone Deficiency

        Growth hormone deficiency (GHD) is a medical condition in which the body does not produce enough growth hormone (GH). GH is a hormone produced by the pituitary gland that is essential for normal growth and development. GHD can cause a variety of symptoms, including short stature, delayed puberty, and decreased muscle mass. Treatment for GHD typically involves hormone replacement therapy, which can help to restore normal growth and development.

        Browse All Tags